14670-94-1 Usage
Description
3,5-Dimethyladamantane-1-carboxylic acid is a white to light yellow crystalline powder that serves as an intermediate in the pharmaceutical industry, specifically for the synthesis of various active pharmaceutical ingredients (APIs).
Uses
Used in Pharmaceutical Industry:
3,5-Dimethyladamantane-1-carboxylic acid is used as a pharmaceutical intermediate for the development and synthesis of active pharmaceutical ingredients (APIs). Its unique chemical structure and properties make it a valuable component in the creation of various medications, contributing to the advancement of pharmaceutical research and drug development.
Used as API Intermediate:
3,5-Dimethyladamantane-1-carboxylic acid plays a crucial role as an intermediate in the production of APIs. Its chemical properties allow for further modification and synthesis of complex molecules, which can be utilized in the development of new drugs and therapeutic agents. This application is essential in the pharmaceutical industry, as it enables the creation of innovative and effective treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 14670-94-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,6,7 and 0 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 14670-94:
(7*1)+(6*4)+(5*6)+(4*7)+(3*0)+(2*9)+(1*4)=111
111 % 10 = 1
So 14670-94-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H20O2/c1-11-3-9-4-12(2,6-11)8-13(5-9,7-11)10(14)15/h9H,3-8H2,1-2H3,(H,14,15)/p-1/t9?,11-,12+,13?
14670-94-1Relevant articles and documents
Novel rimantadine analog and synthetic method thereof
-
, (2019/04/17)
The invention provides a novel rimantadine analog. The novel rimantadine analog has a structure shown in formula (I). The rimantadine analog has high activity and is more beneficial to clinical use and further development and research of drugs.
Enantioselective borohydride reduction of aliphatic ketones catalyzed by ketoiminatocobalt(iii) complex with 1-chlorovinyl axial ligand
Tsubo, Tatsuyuki,Chen, Hsiu-Hui,Yokomori, Minako,Fukui, Kosuke,Kikuchi, Satoshi,Yamada, Tohru
supporting information; scheme or table, p. 780 - 782 (2012/09/22)
For the enantioselective borohydride reduction of aliphatic ketones, the optically active ketoiminatocobalt(II) catalysts was successfully designed based on their axial ligand. Instead of chloroform for the aryl ketone reduction, various axial ligand precursors were examined for the aliphatic ketone. Consequently, 1, 1, 1-trichloroethane was found to be the most effective activator of the cobalt(II) complexes to generate the corresponding 1-chlorovinyl cobalt(III) derivatives as the reactive intermediate. Several aliphatic ketones were successfully reduced to afford the corresponding secondary alcohols with high enantioselectivities.
ADAMANTANOL NITRATES IN NUCLEOPHILIC SUBSTITUTION REACTIONS
Moiseev, I. K.,Bagrii, E. I.,Klimochkin, Yu. N.,Dolgopolova, T. N.,Zemtsova, M. N.,Trakhtenberg, P. L.
, p. 1983 - 1985 (2007/10/02)
-